Elsevier Announces 2007 Journal Impact Factor H...

AMSTERDAM, June 26 /PRNewswire/ --

    - 43 Elsevier Journals Receive Top Category Rank; Journal Citations Grow 
10 Percent; Lancet and Cell Each Increase and Retain Leadership Positions


AMSTERDAM, June 26 /PRNewswire/ --

     Elsevier, the leading publisher of scientific, technical and
medical information products and services, today announced highlights of its
Journal Impact Factor performance in 2007. The 2007 Journal Citation
Reports(c) published by ThomsonReuters, reports that 43 Elsevier journals
ranked number one in their respective categories. In addition, total Elsevier
journal citations grew by 10 percent (compared to an industry average of 8.9
percent).



    In addition, Elsevier's flagship journals, Cell and The Lancet, both
increased in impact factor: Cell jumped to 29.887 (#1 research journal in
Cell Biology) and The Lancet improved by 2.8 points to 28.6.



    The impact factor is a measure of the frequency with which the
average article in a journal has been cited in a particular year. The impact
factor helps to evaluate a journal's relative importance, especially when
compared with others in the same field.



    Glen Campbell, Senior Vice President of U.S. Health Sciences
Journals said, "Our impact factors performance is a strong sign that our
continued effort to publish trusted, leading-edge STM information is
contributing significantly to the continuous cycle of discovery and progress.
These results reflect the truly dedicated efforts of our editors, authors,
reviewers and publishing staff."



    "We are very proud of the strong showing for Elsevier's
journals this year both in impact factors and total number of article
citations," remarked Martin Tanke, Managing Director of Science and
Technology Journals. "This would not have been possible without our 7,000
editors who have helped to guide and build their journals. Building world
class content in partnership with our authors, editors and publishing is one
of our foremost goals."



    Some of the journals that led their respective categories
include: Journal of the American Medical Informatics Association (#1 in
Medical Informatics); Pain (#1 in Anesthesiology); Annals of Emergency
Medicine (#1 in Emergency Medicine); Journal of Allergy & Clinical Immunology
(#1 in Allergy); Water Research (#1 in Water Resources); Trends in Ecology &
Evolution (#1 in Evolutionary Biology); Biomaterials (#1 in Materials
Science, Biomaterials); Cognitive Brain Research (#1 in Computer Science,
Artificial Intelligence); Lancet Infectious Diseases (#1 in Infectious
Diseases); Lancet Neurology (#1 in Clinical Neurology); and Progress in
Polymer Science (#1 in Polymer Science).



About Elsevier

    Elsevier is a world-leading publisher of scientific, technical
and medical information products and services. Working in partnership with
the global science and health communities, Elsevier's 7,000 employees in over
70 offices worldwide publish more than 2,000 journals and 1,900 new books per
year, in addition to offering a suite of innovative electronic products, such
as ScienceDirect (http://www.sciencedirect.com/), MD Consult (
http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/),
bibliographic databases, and online reference works.



    Elsevier (http://www.elsevier.com/) is a global business
headquartered in Amsterdam, The Netherlands and has offices worldwide.
Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a
world-leading publisher and information provider. Operating in the science
and medical, legal, education and business-to-business sectors, Reed Elsevier
provides high-quality and flexible information solutions to users, with
increasing emphasis on the Internet as a means of delivery. Reed Elsevier's
ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK
and ENL (New York Stock Exchange).



    
    Contact:
    
    Tom Reller,
    [phone],
    [e-mail] ;
    
    Ylann Schemm,
    [phone],
    [e-mail] .